Suvorsen API

Name	Suvorsen
Chinese name	苏沃雷生
Cas Number	1030377-33-3
Source	India
Qualifications	-/-/-/-/-

The drug was developed by Merck in the United States, and was first approved for marketing in the United States in August 2014 and approved for marketing in Japan in the same year. Suvorexin is a representative drug of non-central nervous system hypnotic drugs. It is a selective orexin receptor antagonist. It is the world's first insomnia treatment drug with orexin receptor as the site of action. It is used to treat falling asleep and sleeping difficulties. (Insomnia) patients. Since the action site of this species is not the central nervous system, compared with traditional hypnotic drugs, it has the advantages of being safer and more effective. Clinical studies have shown that insomnia patients who are resistant to antidepressant sedatives and benzodiazepine sedatives, Suvorexan has a good therapeutic effect. Suvorexan is recommended by relevant guidelines and has a good clinical prospect.

Hot Tags: suvorsen api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Adapalene API, Lercanidipine Hydrochloride API, Canagliflozin API, Perindopril Arginine API, Tetrabenazine API, Pleasant API

• Previous: Ivabradine Hydrochloride API
• Next: Nafamostat Mesylate API